Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial) (Q77309343)
Jump to navigation
Jump to search
scientific article published on 01 August 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial) |
scientific article published on 01 August 1998 |
Statements
Incidence, outcome and prediction of early clinical events following percutaneous transluminal coronary angioplasty. A comparison between treatment with reviparin and unfractionated heparin/placebo (results of a substudy of the REDUCE trial) (English)
M B Preisack
R Bonan
C Meisner
V Eschenfelder